鈴木 栄治

Last Update: 2020/07/07 17:27:06

Print

Name(Kanji/Kana/Abecedarium Latinum)
鈴木 栄治/スズキ エイジ/Suzuki, Eizi
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Associate Professor
Faculty
Org1 Job title
医学部
Concurrent Affiliation
Org1 Job title
Graduate Schools Medicine
Contact Address
Type Address(Japanese) Address(English)
Office 京都市左京区聖護院川原町54 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
Phone
Type Number
Office 075-751-3660
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本外科学会
日本乳癌学会
日本乳房オンコプラスティックサージェリー学会
日本癌治療学会
Academic Organizations Overaseas You are Affiliated to
Organization name Country
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Breast Surgeons
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 岡山大学
researchmap URL
https://researchmap.jp/7000009073
Research Topics
(Japanese)
腫瘍微小環境における免疫細胞の役割
(English)
A role of immune cells in tumor microenvironment
Fields of research (key words)
Key words(Japanese) Key words(English)
腫瘍免疫 Tumor Immunity
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Tomoharu Sugie, Eiichi Sato, Minoru Miyashita, Rin Yamaguchi, Takashi Sakatani, Yuji Kozuka, Suzuko Moritani, Eiji Suzuki, Kazuhiro Kakimi, Yoshiki Mikami, Takuya Moriya Tomoharu Sugie, Eiichi Sato, Minoru Miyashita, Rin Yamaguchi, Takashi Sakatani, Yuji Kozuka, Suzuko Moritani, Eiji Suzuki, Kazuhiro Kakimi, Yoshiki Mikami, Takuya Moriya Tomoharu Sugie, Eiichi Sato, Minoru Miyashita, Rin Yamaguchi, Takashi Sakatani, Yuji Kozuka, Suzuko Moritani, Eiji Suzuki, Kazuhiro Kakimi, Yoshiki Mikami, Takuya Moriya Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer Breast Cancer, 27, 4, 519-526 Breast Cancer, 27, 4, 519-526 Breast Cancer, 27, 4, 519-526 2020/07 Refereed Research paper(scientific journal) Disclose to all
Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer Poster Session Abstracts Poster Session Abstracts Poster Session Abstracts 2020/02/15 Refereed Research paper(international conference proceedings) Disclose to all
Masahiro Kawashima, Mariko Tokiwa, Tomomi Nishimura, Yukiko Kawata, Masahiro Sugimoto, Tatsuki R. Kataoka, Takaki Sakurai, Keiko Iwaisako, Eiji Suzuki, Masatoshi Hagiwara, Adrian L. Harris, Masakazu Toi Masahiro Kawashima, Mariko Tokiwa, Tomomi Nishimura, Yukiko Kawata, Masahiro Sugimoto, Tatsuki R. Kataoka, Takaki Sakurai, Keiko Iwaisako, Eiji Suzuki, Masatoshi Hagiwara, Adrian L. Harris, Masakazu Toi Masahiro Kawashima, Mariko Tokiwa, Tomomi Nishimura, Yukiko Kawata, Masahiro Sugimoto, Tatsuki R. Kataoka, Takaki Sakurai, Keiko Iwaisako, Eiji Suzuki, Masatoshi Hagiwara, Adrian L. Harris, Masakazu Toi High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer British Journal of Cancer, 122, 2, 245-257 British Journal of Cancer, 122, 2, 245-257 British Journal of Cancer, 122, 2, 245-257 2020/01 Refereed Research paper(scientific journal) Disclose to all
Eizi Suzuki Masuda N, Ohtani S, Takano T, Inoue K, Suzuki E, Nakamura R, Bando H, Ito Y, Ishida K, Yamanaka T, Kuroi K, Yasojima H, Kasai H, Takakusa T, Sakurai T, Kataoka T, Morita S, Ohno S, Toi M Eizi Suzuki A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer A randomized, 3 arm, neoadjuvant, phase 2 study comparing docetaxel+carboplatin+trastuzumab+pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T DM1+P), and T DM1+P in HER2 positive primary breast cancer Breast Cancer Research and Treatment Breast Cancer Research and Treatment Breast Cancer Research and Treatment 2019 Refereed Disclose to all
Eizi Suzuki Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T Eizi Suzuki The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation Radiation Oncology Radiation Oncology Radiation Oncology 2019 Refereed Disclose to all
Eizi Suzuki Uchida M, Sugie C, Yoshimura M, Suzuki E, Shibamoto Y, Hiraoka M, Akechi T Eizi Suzuki Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Factors associated with a preference for disclosure of life expectancy information from physicians: a cross-sectional survey of cancer patients undergoing radiation therapy Support Care Cancer Support Care Cancer Support Care Cancer 2019 Refereed Disclose to all
Suzuki E Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M Suzuki E Alteration of specific cytokine expression patterns with breast cancer Alteration of specific cytokine expression patterns with breast cancer Alteration of specific cytokine expression patterns with breast cancer Sci Rep Sci Rep 2019 Refereed Disclose to all
Suzuki E Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M Suzuki E Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients Breast Cancer Breast Cancer Breast Cancer 2018 Refereed English Disclose to all
Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka T, Hamazaki Y, Minato N, Toi M Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer Combined effects of neoadjuvant letrozole and zoledronic acid on gdT cells in postmenopausal women with early-stage breast cancer The Breast The Breast The Breast 2018 Refereed Disclose to all
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety A cross sectional study of agreement between the Hospital Anxiety and Depression Scale, patient- and radiation oncologist-reported single-item assessment of depression and anxiety Psychooncology Psychooncology Psychooncology 2018 Refereed Disclose to all
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence Breast Cancer Breast Cancer Breast Cancer 2018 Refereed Disclose to all
Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Mackenzie L, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D’Este C, Yoshimura M, Toi M Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan Agreement between patients’ and radiation oncologists’ cancer diagnosis and prognosis perceptions: A cross sectional study in Japan PLoS One PLoS One PLoS One 2018 Refereed Disclose to all
Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Matlung HL, Babes L, Zhao XW, van Houdt M, Treffers LW, van Rees DJ, Szilagyi K, Schornagel K, Janssen H, Halonen P, Lieftink C, Beijersbergen RL, Leusen JHW, Boelens JJ, Kuhnle I, Van Der Werff Ten, Bosch J, Seeger K, Rutella S, Pagliara D, Matozaki T, Suzuki E, Menke-van der Houven, van Oordt CW, van Bruggen R, Roos D, van Lier RAW, Kuijpers TW, Kubes P, van den Berg TK Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Neutrophils kill antibody-opsonized cancer cells by trogoptosis Cell Rep Cell Rep Cell Rep 2018 Refereed Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 2017/09 Refereed English Research paper(scientific journal) Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer BREAST CANCER, 24, 1, 111-120 BREAST CANCER, 24, 1, 111-120 BREAST CANCER, 24, 1, 111-120 2017/01 Refereed English Research paper(scientific journal) Disclose to all
Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 2017/01 Refereed English Research paper(scientific journal) Disclose to all
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 2016/08 Refereed English Research paper(scientific journal) Disclose to all
Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 2016/01 Refereed English Research paper(scientific journal) Disclose to all
Chiyuki Ueshima, Tatsuki R. Kataoka, Masahiro Hirata, Ayako Furuhata, Eiji Suzuki, Masakazu Toi, Tatsuaki Tsuruyama, Yoshimichi Okayama, Hironori Haga Chiyuki Ueshima, Tatsuki R. Kataoka, Masahiro Hirata, Ayako Furuhata, Eiji Suzuki, Masakazu Toi, Tatsuaki Tsuruyama, Yoshimichi Okayama, Hironori Haga Chiyuki Ueshima, Tatsuki R. Kataoka, Masahiro Hirata, Ayako Furuhata, Eiji Suzuki, Masakazu Toi, Tatsuaki Tsuruyama, Yoshimichi Okayama, Hironori Haga The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion CANCER IMMUNOLOGY RESEARCH, 3, 8, 871-880 CANCER IMMUNOLOGY RESEARCH, 3, 8, 871-880 CANCER IMMUNOLOGY RESEARCH, 3, 8, 871-880 2015/08 Refereed English Research paper(scientific journal) Disclose to all
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients BMC CANCER, 15 BMC CANCER, 15 BMC CANCER, 15 2015/02 Refereed English Research paper(scientific journal) Disclose to all
Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato Sumi E, Sugie T, Yoshimura K, Tada H, Ikeda T, Suzuki E, Tanaka Y, Teramukai S, Shimizu A, Toi M, Minato N Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. Journal of translational medicine, 12, 310-310 J Transl Med, 12, 310-310 Journal of translational medicine, 12, 310-310 2014/11/25 Refereed English Disclose to all
Jon G. Quatromoni, Eiji Suzuki, Olugbenga Okusanya, Brendan F. Judy, Pratik Bhojnagarwala, Ollin Venegas, Evgeniy Eruslanov, Jarrod D. Predina, Steven M. Albelda, Sunil Singhal Jon G. Quatromoni, Eiji Suzuki, Olugbenga Okusanya, Brendan F. Judy, Pratik Bhojnagarwala, Ollin Venegas, Evgeniy Eruslanov, Jarrod D. Predina, Steven M. Albelda, Sunil Singhal Jon G. Quatromoni, Eiji Suzuki, Olugbenga Okusanya, Brendan F. Judy, Pratik Bhojnagarwala, Ollin Venegas, Evgeniy Eruslanov, Jarrod D. Predina, Steven M. Albelda, Sunil Singhal The timing of TGF-beta inhibition affects the generation of antigen-specific CD8(+) T Cells The timing of TGF-beta inhibition affects the generation of antigen-specific CD8(+) T Cells The timing of TGF-beta inhibition affects the generation of antigen-specific CD8(+) T Cells BMC IMMUNOLOGY, 14 BMC IMMUNOLOGY, 14 BMC IMMUNOLOGY, 14 2013/07 Refereed English Research paper(scientific journal) Disclose to all
Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 2011/11 Refereed English Research paper(scientific journal) Disclose to all
Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast SURGERY TODAY, 41, 3, 328-332 SURGERY TODAY, 41, 3, 328-332 SURGERY TODAY, 41, 3, 328-332 2011/03 Refereed English Research paper(scientific journal) Disclose to all
Zvi G. Fridlender, Jing Sun, Sunil Singhal, Veena Kapoor, Guanjun Cheng, Eiji Suzuki, Steven M. Albelda Zvi G. Fridlender, Jing Sun, Sunil Singhal, Veena Kapoor, Guanjun Cheng, Eiji Suzuki, Steven M. Albelda Zvi G. Fridlender, Jing Sun, Sunil Singhal, Veena Kapoor, Guanjun Cheng, Eiji Suzuki, Steven M. Albelda Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms MOLECULAR THERAPY, 18, 11, 1947-1959 MOLECULAR THERAPY, 18, 11, 1947-1959 MOLECULAR THERAPY, 18, 11, 1947-1959 2010/11 Refereed English Research paper(scientific journal) Disclose to all
Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer BREAST CANCER, 17, 3, 199-204 BREAST CANCER, 17, 3, 199-204 BREAST CANCER, 17, 3, 199-204 2010/07 Refereed English Research paper(scientific journal) Disclose to all
Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer ONCOLOGY REPORTS, 22, 2, 273-278 ONCOLOGY REPORTS, 22, 2, 273-278 ONCOLOGY REPORTS, 22, 2, 273-278 2009/08 Refereed English Research paper(scientific journal) Disclose to all
Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells ONCOLOGY, 77, 3-4, 182-191 ONCOLOGY, 77, 3-4, 182-191 ONCOLOGY, 77, 3-4, 182-191 2009 Refereed English Research paper(scientific journal) Disclose to all
Eiji Suzuki, Masakazu Toi Eiji Suzuki, Masakazu Toi Eiji Suzuki, Masakazu Toi Improving the efficacy of trastuzumab in breast cancer Improving the efficacy of trastuzumab in breast cancer Improving the efficacy of trastuzumab in breast cancer CANCER SCIENCE, 98, 6, 767-771 CANCER SCIENCE, 98, 6, 767-771 CANCER SCIENCE, 98, 6, 767-771 2007/06 Refereed English Disclose to all
Eiji Suzuki, Jing Sun, Veena Kapoor, Arminder Singh Jassar, Steven M. Albelda Eiji Suzuki, Jing Sun, Veena Kapoor, Arminder Singh Jassar, Steven M. Albelda Eiji Suzuki, Jing Sun, Veena Kapoor, Arminder Singh Jassar, Steven M. Albelda Gemcitabine as significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects Gemcitabine as significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects Gemcitabine as significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects CANCER BIOLOGY & THERAPY, 6, 6, 880-885 CANCER BIOLOGY & THERAPY, 6, 6, 880-885 CANCER BIOLOGY & THERAPY, 6, 6, 880-885 2007/06 Refereed English Research paper(scientific journal) Disclose to all
Eiji Suzuki, Samuel Kim, H. -Kam Cheung, Michael J. Corbley, Xiamei Zhang, Lihong Sun, Feng Shan, Juswinder Singh, Wen-Cherng Lee, Steven M. Albelda, Leona E. Ling Eiji Suzuki, Samuel Kim, H. -Kam Cheung, Michael J. Corbley, Xiamei Zhang, Lihong Sun, Feng Shan, Juswinder Singh, Wen-Cherng Lee, Steven M. Albelda, Leona E. Ling Eiji Suzuki, Samuel Kim, H. -Kam Cheung, Michael J. Corbley, Xiamei Zhang, Lihong Sun, Feng Shan, Juswinder Singh, Wen-Cherng Lee, Steven M. Albelda, Leona E. Ling A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection CANCER RESEARCH, 67, 5, 2351-2359 CANCER RESEARCH, 67, 5, 2351-2359 CANCER RESEARCH, 67, 5, 2351-2359 2007/03 Refereed English Research paper(scientific journal) Disclose to all
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 2007/03 Refereed English Research paper(scientific journal) Disclose to all
AS Jassar, E Suzuki, Kapoor, V, J Sun, MB Silverberg, LM Cheung, MD Burdick, RM Strieter, LM Ching, LR Kaiser, SM Albelda AS Jassar, E Suzuki, Kapoor, V, J Sun, MB Silverberg, LM Cheung, MD Burdick, RM Strieter, LM Ching, LR Kaiser, SM Albelda AS Jassar, E Suzuki, Kapoor, V, J Sun, MB Silverberg, LM Cheung, MD Burdick, RM Strieter, LM Ching, LR Kaiser, SM Albelda Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8(+) T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8(+) T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8(+) T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma CANCER RESEARCH, 65, 24, 11752-11761 CANCER RESEARCH, 65, 24, 11752-11761 CANCER RESEARCH, 65, 24, 11752-11761 2005/12 Refereed English Research paper(scientific journal) Disclose to all
E Suzuki, Kapoor, V, AS Jassar, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, AS Jassar, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, AS Jassar, LR Kaiser, SM Albelda Gemcitabine selectively eliminates splenic Gr-1(+)/CD11b(+) myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity Gemcitabine selectively eliminates splenic Gr-1(+)/CD11b(+) myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity Gemcitabine selectively eliminates splenic Gr-1(+)/CD11b(+) myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity CLINICAL CANCER RESEARCH, 11, 18, 6713-6721 CLINICAL CANCER RESEARCH, 11, 18, 6713-6721 CLINICAL CANCER RESEARCH, 11, 18, 6713-6721 2005/09 Refereed English Research paper(scientific journal) Disclose to all
Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Wilderman, M, Sun, J, Khan, M, Vachani, A, Suzuki E, Kinnery, P, Steman, D, Kaiser, L, Albelda, S.M Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Intrapulmonary interferon-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of lung adenocarcinoma via a combination of direct toxicity, NK cell, and CD8 T-cell mediated effects Cancer Research Cancer Research Cancer Research 2005 Refereed Disclose to all
E Suzuki, Kapoor, V, HK Cheung, LE Ling, PA DeLong, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, HK Cheung, LE Ling, PA DeLong, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, HK Cheung, LE Ling, PA DeLong, LR Kaiser, SM Albelda Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity CLINICAL CANCER RESEARCH, 10, 17, 5907-5918 CLINICAL CANCER RESEARCH, 10, 17, 5907-5918 CLINICAL CANCER RESEARCH, 10, 17, 5907-5918 2004/09 Refereed English Research paper(scientific journal) Disclose to all
K Matsuoka, K Tsukuda, M Suda, K Kobayashi, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, H Doihara, N Shimizu K Matsuoka, K Tsukuda, M Suda, K Kobayashi, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, H Doihara, N Shimizu K Matsuoka, K Tsukuda, M Suda, K Kobayashi, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, H Doihara, N Shimizu The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil INTERNATIONAL JOURNAL OF ONCOLOGY, 24, 1, 217-222 INTERNATIONAL JOURNAL OF ONCOLOGY, 24, 1, 217-222 INTERNATIONAL JOURNAL OF ONCOLOGY, 24, 1, 217-222 2004/01 Refereed English Research paper(scientific journal) Disclose to all
E Suzuki, T Ota, K Tsukuda, A Okita, K Matsuoka, M Murakami, H Doihara, N Shimizu E Suzuki, T Ota, K Tsukuda, A Okita, K Matsuoka, M Murakami, H Doihara, N Shimizu E Suzuki, T Ota, K Tsukuda, A Okita, K Matsuoka, M Murakami, H Doihara, N Shimizu nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation INTERNATIONAL JOURNAL OF CANCER, 108, 2, 207-211 INTERNATIONAL JOURNAL OF CANCER, 108, 2, 207-211 INTERNATIONAL JOURNAL OF CANCER, 108, 2, 207-211 2004/01 Refereed English Research paper(scientific journal) Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
仙田 典子, 川田 有希子, 川口 展子, 川島 雅央, 高田 正泰, 本田 明夏, 鈴木 栄治, 村上 弘美, 山田 崇弘, 露木 茂, 山内 清明, 高原 祥子, 芳林 浩史, 山神 和彦, 岡村 隆仁, 加藤 大典, 眞島 奨, 小杉 眞司, 小川 誠司, 戸井 雅和 仙田 典子, 川田 有希子, 川口 展子, 川島 雅央, 高田 正泰, 本田 明夏, 鈴木 栄治, 村上 弘美, 山田 崇弘, 露木 茂, 山内 清明, 高原 祥子, 芳林 浩史, 山神 和彦, 岡村 隆仁, 加藤 大典, 眞島 奨, 小杉 眞司, 小川 誠司, 戸井 雅和 実臨床における遺伝性乳癌の拾い上げ 実臨床における遺伝性乳癌の拾い上げ 日本乳癌学会総会プログラム抄録集, 27回, 711-711 日本乳癌学会総会プログラム抄録集, 27回, 711-711 , 27回, 711-711 2019/07 Japanese Disclose to all
本田 茉也, 片岡 正子, 尾仲 桜子, 宮川 哲, 川瀬 貫互, 金尾 昌太郎, 大西 奈都子, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 飯間 麻美, 大橋 茜, 大野 文美, 太田 理恵, 鈴木 栄治, 高田 正泰, 河口 浩介, 鳥井 雅恵, 戸井 雅和, 富樫 かおり 本田 茉也, 片岡 正子, 尾仲 桜子, 宮川 哲, 川瀬 貫互, 金尾 昌太郎, 大西 奈都子, 三宅 可奈江, 片岡 竜貴, 桜井 孝規, 飯間 麻美, 大橋 茜, 大野 文美, 太田 理恵, 鈴木 栄治, 高田 正泰, 河口 浩介, 鳥井 雅恵, 戸井 雅和, 富樫 かおり 乳房MRIカテゴリー4のサブカテゴリー導入による乳房病変の層別化 乳房MRIカテゴリー4のサブカテゴリー導入による乳房病変の層別化 日本乳癌学会総会プログラム抄録集, 27回, 470-470 日本乳癌学会総会プログラム抄録集, 27回, 470-470 , 27回, 470-470 2019/07 Japanese Disclose to all
大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 三宅 可奈江, 大橋 茜, 太田 理恵, 片岡 竜貴, 桜井 孝規, 鈴木 栄治, 戸井 雅和, 富樫 かおり 大野 文美, 片岡 正子, 飯間 麻美, 本田 茉也, 三宅 可奈江, 大橋 茜, 太田 理恵, 片岡 竜貴, 桜井 孝規, 鈴木 栄治, 戸井 雅和, 富樫 かおり 高分解能拡散強調画像による乳癌病変の評価 病理所見との比較検討 高分解能拡散強調画像による乳癌病変の評価 病理所見との比較検討 日本乳癌学会総会プログラム抄録集, 27回, 471-471 日本乳癌学会総会プログラム抄録集, 27回, 471-471 , 27回, 471-471 2019/07 Japanese Disclose to all
太田 理恵, 片岡 正子, 金尾 昌太郎, 本田 茉也, 飯間 麻美, 大野 文美, 大橋 茜, 三宅 可奈江, 桜井 孝規, 片岡 竜貴, 高田 正泰, 鈴木 栄治, 戸井 雅和, 富樫 かおり 太田 理恵, 片岡 正子, 金尾 昌太郎, 本田 茉也, 飯間 麻美, 大野 文美, 大橋 茜, 三宅 可奈江, 桜井 孝規, 片岡 竜貴, 高田 正泰, 鈴木 栄治, 戸井 雅和, 富樫 かおり 術前薬物療法後の乳房MRI pCR診断におけるDWI所見の有用性 術前薬物療法後の乳房MRI pCR診断におけるDWI所見の有用性 日本乳癌学会総会プログラム抄録集, 27回, 621-621 日本乳癌学会総会プログラム抄録集, 27回, 621-621 , 27回, 621-621 2019/07 Japanese Disclose to all
M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi M. Kawashima, T. Nishimura, Y. Kawata, E. Suzuki, M. Toi High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway High-resolution imaging mass spectrometry identified the missing link between fatty acid remodeling of phosphatidylinositols and the activity of PD1-related immune checkpoint pathway Translational Immunometabolism Translational Immunometabolism Translational Immunometabolism 2018/06 English Summary of the papers read (international conference) Disclose to all
高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 松本 純明, 鳥井 雅恵, 川口 展子, 西野 裕人, 瀬尾 智, 波多野 悦朗, 戸井 雅和 センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション センチネルリンパ節生検の今後に向けた取り組み 蛍光色素法センチネルリンパ節生検におけるプロジェクションマッピングを用いたリアルタイムナビゲーション 日本乳癌学会総会プログラム抄録集, 26回, 317-317 日本乳癌学会総会プログラム抄録集, 26回, 317-317 日本乳癌学会総会プログラム抄録集, 26回, 317-317 2018/05 Japanese Disclose to all
川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 川島 雅央, 常盤 麻里子, 西村 友美, 川田 有希子, 片岡 竜樹, 桜井 孝規, 祝迫 惠子, 鈴木 栄治, 戸井 雅和 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 新規バイオマーカーの臨床応用、予後予測因子・治療効果予測因子 脂質代謝物は乳癌の新しいバイオマーカーとなるか? 高解像度質量顕微鏡の解析から見えてきた事 日本乳癌学会総会プログラム抄録集, 26回, 303-303 日本乳癌学会総会プログラム抄録集, 26回, 303-303 日本乳癌学会総会プログラム抄録集, 26回, 303-303 2018/05 Japanese Disclose to all
清水 華子, 石黒 洋, 高田 正泰, 山口 絢音, 鳥井 雅恵, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 清水 華子, 石黒 洋, 高田 正泰, 山口 絢音, 鳥井 雅恵, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 トリプルネガティブ乳がんにおけるシスプラチンを含む術前化学療法の治療効果と予後、その予測因子の探索 トリプルネガティブ乳がんにおけるシスプラチンを含む術前化学療法の治療効果と予後、その予測因子の探索 第26回日本乳癌学会総会プログラム抄録集, 462 第26回日本乳癌学会総会プログラム抄録集, 462 , 462 2018/05 Refereed Japanese Summary of the papers read (national conference and other science council) Disclose to all
小味 由里絵, 川口 展子, 松本 純明, 川島 雅央, 鳥井 雅恵, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 石黒 洋, 戸井 雅和 小味 由里絵, 川口 展子, 松本 純明, 川島 雅央, 鳥井 雅恵, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 石黒 洋, 戸井 雅和 アンスラサイクリン系薬剤に伴う口腔粘膜炎の口腔内冷却による予防の取り組み アンスラサイクリン系薬剤に伴う口腔粘膜炎の口腔内冷却による予防の取り組み 第26回日本乳癌学会総会プログラム抄録集, 463 第26回日本乳癌学会総会プログラム抄録集, 463 , 463 2018/05 Refereed Japanese Summary of the papers read (national conference and other science council) Disclose to all
山口 絢音, 石黒 洋, 鳥井 雅恵, 松本 純明, 川口 展子, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 山口 絢音, 石黒 洋, 鳥井 雅恵, 松本 純明, 川口 展子, 高田 正泰, 鈴木 栄治, 竹内 恵, 佐藤 史顕, 戸井 雅和 Basal-like乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析 Basal-like乳がん症例におけるシスプラチン含む術前化学療法の予後への影響に関する後向き解析 第25回日本乳癌学会総会プログラム抄録集, 352 第25回日本乳癌学会総会プログラム抄録集, 352 , 352 2017/07 Refereed Japanese Summary of the papers read (national conference and other science council) Disclose to all
Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji SUzuki, Masashi Inoue, Isao Kii, Tatsuki R. Karaoke, Masahiro Hiram, Keiko Iwaisako, Pu Fengling, Mariko Niche, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer Neuropilin-1 expressing macrophages promote neuropilin-1 expression on lymphocytes by direct interaction and exert antitumor activity in HER2 positive breast cancer CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 English Summary of the papers read (international conference) Disclose to all
Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Shun Kawaguchi, Eiji Suzuki, Kosuke Kawaguchi, Fengling Pu, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation Humoral factors of breast tumor environment may boost PD-1 and CTLA4 gene expression of T cells, which has already been upregulated by CD28 stimulation CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 English Summary of the papers read (international conference) Disclose to all
Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Eiji Suzuki, Masashi Inoue, Shinji Ito, Junko Satoh, Kosuke Kawaguchi, Ayane Yamaguchi, Moe Tsuda, Masakazu Toi Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 English Summary of the papers read (international conference) Disclose to all
Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Ayane Yamaguchi, Eiji Suzuki, Kosuke Kawaguchi, Mariko Nishie, Moe Tsuda, Masakazu Toi Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 Direct immune cell contact to basal-like triple negative breast cancer cells evokes downregulation of EGFR and PD-L1 CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/07 English Summary of the papers read (international conference) Disclose to all
矢内 勢司, 松本 純弘, 古武 剛, 林 雪, 高田 正泰, 鈴木 栄治, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 矢内 勢司, 松本 純弘, 古武 剛, 林 雪, 高田 正泰, 鈴木 栄治, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 乳腺間質肉腫の2例 乳腺間質肉腫の2例 日本乳癌学会総会プログラム抄録集24回, 618 日本乳癌学会総会プログラム抄録集24回, 618 , 618 2016/06 Disclose to all
西村 友美, 石黒 洋, 中木村 朋美, 福井 由紀子, 前川 佳奈, 仁尾 万里華, 山口 絢音, 中山 美恵, 林 雪, 古武 剛, 矢内 勢司, 松本 純明, 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 戸井 雅和 西村 友美, 石黒 洋, 中木村 朋美, 福井 由紀子, 前川 佳奈, 仁尾 万里華, 山口 絢音, 中山 美恵, 林 雪, 古武 剛, 矢内 勢司, 松本 純明, 高田 正泰, 竹内 恵, 鈴木 栄治, 佐藤 史顕, 戸井 雅和 日本人乳癌患者におけるオランザピン(アプレピタント非併用) の化学療法誘発性悪心嘔吐抑制効果 日本人乳癌患者におけるオランザピン(アプレピタント非併用) の化学療法誘発性悪心嘔吐抑制効果 第24回日本乳癌学会学術総会プログラム抄録集24回 第24回日本乳癌学会学術総会プログラム抄録集24回 2016/06 Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Shinji Ohno, Hiroko Bando, Hiroshi Ishiguro, Kenichi Inoue, Naohito Yamamoto, Katsumasa Kuroi, Satoshi Morita, Norikazu Masuda, Masakazu Toi Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). Analysis of tumor infiltrating lymphocytes in HER2-positive primary breast cancer treated with neoadjuvant lapatinib and trastuzumab: The NeoLath study (JBCRG-16). JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 JOURNAL OF CLINICAL ONCOLOGY, 34, 15 2016/05 English Summary of the papers read (international conference) Disclose to all
K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 English Summary of the papers read (international conference) Disclose to all
K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi K. Kawaguchi, E. Suzuki, Y. Yamamoto, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis in breast cancer and its negative association with treatment outcome CANCER RESEARCH, 76 CANCER RESEARCH, 76 CANCER RESEARCH, 76 2016/02 English Summary of the papers read (international conference) Disclose to all
高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 高田正泰, 竹内恵, 鈴木栄治, 松本純明, 佐藤史顕, 中山美恵, 奥田智子, 西野裕人, 瀬尾智, 波多野悦朗, 波多野悦朗, 戸井雅和 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 可視光術野投影装置を用いた乳癌蛍光色素法センチネルリンパ節生検に関する探索的試験 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 日本癌治療学会学術集会(Web), 54th, ROMBUNNO.WS18‐4 (WEB ONLY) 2016 Japanese Disclose to all
K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi K. Kawaguchi, Y. Yamamoto, E. Suzuki, K. Saito, M. Toi Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer Upregulation of the interleukin 17/granulocyte-colony stimulating factor/fibroblast growth factor axis and its correlation with indoleamine 2,3-dioxygenase in breast cancer ANNALS OF ONCOLOGY, 26, 11-11 ANNALS OF ONCOLOGY, 26, 11-11 ANNALS OF ONCOLOGY, 26, 11-11 2015/12 English Summary of the papers read (international conference) Disclose to all
Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuta Shibamoto, Masahiro Hiraoka, Masakazu Toi, Tatsuo Akechi THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY THE EXPERIENCES AND PREFERENCES OF SHARED DECISION MAKING AND THEIR ASSOCIATED FACTORS AMONG CANCER PATIENTS UNDERGOING RADIATION THERAPY Asia-Pacific Journal of Clinical Oncology, 11, 145-145 Asia-Pacific Journal of Clinical Oncology, 11, 145-145 Asia-Pacific Journal of Clinical Oncology, 11, 145-145 2015/11 English Summary of the papers read (international conference) Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Mariko Nishie, Masakazu Toi Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients Immune signatures may differ between early operable breast cancer and metastatic breast cancer patients ANNALS OF ONCOLOGY, 26, 77-77 ANNALS OF ONCOLOGY, 26, 77-77 ANNALS OF ONCOLOGY, 26, 77-77 2015/11 English Summary of the papers read (international conference) Disclose to all
鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 鈴木 栄治, 山口 絢音, 河口 浩介, 平田 勝啓, 片岡 竜貴, 西江 万梨子, 羽賀 博典, 戸井 雅和 乳癌微小環境におけるトロゴサイトーシスの役割 乳癌微小環境におけるトロゴサイトーシスの役割 乳癌微小環境におけるトロゴサイトーシスの役割 日本癌治療学会誌, 50, 3, 552-552 日本癌治療学会誌, 50, 3, 552-552 日本癌治療学会誌, 50, 3, 552-552 2015/09 English Disclose to all
河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 河口 浩介, 鈴木 栄治, 片岡 竜樹, 平田 勝啓, 山口 絢音, 西江 万梨子, 羽賀 博典, 戸井 雅和 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 乳癌における原発巣と転移巣のPD-L1発現状況についての検討 日本癌治療学会誌, 50, 3, 555-555 日本癌治療学会誌, 50, 3, 555-555 日本癌治療学会誌, 50, 3, 555-555 2015/09 English Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model Knockdown of neuropilin-1 in monocytes impaired lymphocyte migration and anti-tumor activity in a humanized mouse model CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 English Summary of the papers read (international conference) Disclose to all
Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Ayane Yamaguchi, Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Masakazu Toi Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients Upregulation of mRNA of CD80, FOXP3, NKG2D and PD-L1 in peripheral blood mononuclear cells is associated with metastatic breast cancer patients CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 English Summary of the papers read (international conference) Disclose to all
Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Mariko Nishie, Eiji Suzuki, Kosuke Kawaguchi, Keiko Sakamoto, Yuji Fukushima, Masakazu Hattori, Tomoharu Sugie, Masakazu Toi Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity Downregulation of ATP6V1B1 in HER2-overexpressing human breast cancer cell line leads resistance against trastuzumab-mediated antibody-dependent cellular cytotoxicity CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 English Summary of the papers read (international conference) Disclose to all
Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi Eiji Suzuki, Ayane Yamaguchi, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Masakazu Toi EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients CANCER RESEARCH, 75 CANCER RESEARCH, 75 CANCER RESEARCH, 75 2015/08 English Summary of the papers read (international conference) Disclose to all
山口 絢音, 鈴木 栄治, 川島 雅央, 高田 正泰, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 山口 絢音, 鈴木 栄治, 川島 雅央, 高田 正泰, 竹内 恵, 石黒 洋, 佐藤 史顕, 戸井 雅和 腫瘍浸潤EGFR陽性免疫細胞とトリプルネガティブ乳癌の組織グレードとの関連性 腫瘍浸潤EGFR陽性免疫細胞とトリプルネガティブ乳癌の組織グレードとの関連性 日本乳癌学会学術総会プログラム抄録集23回, 532 日本乳癌学会学術総会プログラム抄録集23回, 532 , 532 2015/07 Disclose to all
河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 河口 浩介, 鈴木 栄治, 喜井 勲, 片岡 竜貴, 平田 勝啓, 羽賀 博典, 萩原 正敏, 戸井 雅和 Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する Neuropollin-1陽性免疫細胞はトラスツズマブによる免疫応答を惹起し抗腫瘍活性を誘導する 日本乳癌学会総会プログラム抄録集, 23回, 352-352 日本乳癌学会総会プログラム抄録集, 23回, 352-352 日本乳癌学会総会プログラム抄録集, 23回, 352-352 2015/07 Japanese Disclose to all
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi A role of trogocytosis of immune cells in breast tumor microenvironment A role of trogocytosis of immune cells in breast tumor microenvironment A role of trogocytosis of immune cells in breast tumor microenvironment INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 36, S16-S16 2015 English Summary of the papers read (international conference) Disclose to all
Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuuta Shibamoto, Masahiro Hiraoka, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuuta Shibamoto, Masahiro Hiraoka, Tatsuo Akechi Megumi Uchida, Chikao Sugie, Michio Yoshimura, Eiji Suzuki, Yuuta Shibamoto, Masahiro Hiraoka, Tatsuo Akechi FACTORS ASSOCIATED WITH PREFERENCE OF COMMUNICATION ABOUT LIFE EXPECTANCY WITH PHYSICIANS AMONG CANCER PATIENTS UNDER RADIATION THERAPY FACTORS ASSOCIATED WITH PREFERENCE OF COMMUNICATION ABOUT LIFE EXPECTANCY WITH PHYSICIANS AMONG CANCER PATIENTS UNDER RADIATION THERAPY FACTORS ASSOCIATED WITH PREFERENCE OF COMMUNICATION ABOUT LIFE EXPECTANCY WITH PHYSICIANS AMONG CANCER PATIENTS UNDER RADIATION THERAPY ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, 208-208 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, 208-208 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, 208-208 2014/12 English Summary of the papers read (international conference) Disclose to all
Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Eiji Suzuki, Mariko Nishie, Kosuke Kawaguchi, Sunao Tanaka, Masakazu Toi Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 English Summary of the papers read (international conference) Disclose to all
Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi Kosuke Kawaguchi, Eiji Suzuki, Masao Kawashima, Masakazu Toi High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line High neuropilin-1 expression on monocytes is positively associated with trastuzumab-mediated antibody-dependent cellular cytotoxicity of the HER2-overexpressing breast cancer cell line CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 English Summary of the papers read (international conference) Disclose to all
Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Junichi Aratake, Eiji Suzuki, Natsue Uehiro, Mariko Nishie, Kosuke Kawaguchi, Fumiaki Sato, Masakazu Toi Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 CANCER RESEARCH, 74, 19 2014/10 English Summary of the papers read (international conference) Disclose to all
Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste Lisa J. Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Catherine DEste JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST JAPANESE CANCER PATIENTS' PREFERENCES FOR DISCUSSING LIFE EXPECTANCY WITH THEIR RADIATION ONCOLOGIST ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 ANNALS OF ONCOLOGY, 25 2014/10 English Summary of the papers read (international conference) Disclose to all
鳥井 雅恵, 石黒 洋, 高田 正泰, 杉江 知治, 鈴木 栄治, 竹内 恵, 上野 貴之, 金尾 昌太郎, 三上 芳喜, 戸井 雅和 鳥井 雅恵, 石黒 洋, 高田 正泰, 杉江 知治, 鈴木 栄治, 竹内 恵, 上野 貴之, 金尾 昌太郎, 三上 芳喜, 戸井 雅和 基底様(basal-like)乳癌における術前化学療法の検討 基底様(basal-like)乳癌における術前化学療法の検討 日本乳癌学会総会プログラム抄録集21回 P226 日本乳癌学会総会プログラム抄録集21回 P226 2013/06 Disclose to all
Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este AGREEMENT BETWEEN CANCER PATIENTS AND THEIR RADIATION ONCOLOGIST REGARDING DIAGNOSIS AND PROGNOSIS DISCLOSURE EXPERIENCES IN JAPAN AGREEMENT BETWEEN CANCER PATIENTS AND THEIR RADIATION ONCOLOGIST REGARDING DIAGNOSIS AND PROGNOSIS DISCLOSURE EXPERIENCES IN JAPAN AGREEMENT BETWEEN CANCER PATIENTS AND THEIR RADIATION ONCOLOGIST REGARDING DIAGNOSIS AND PROGNOSIS DISCLOSURE EXPERIENCES IN JAPAN ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 268-268 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 268-268 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 268-268 2012/11 English Summary of the papers read (international conference) Disclose to all
Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Rob Sanson-Fisher, Mariko Carey, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Rob Sanson-Fisher, Mariko Carey, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Rob Sanson-Fisher, Mariko Carey, Hiromi Asada, Masakazu Toi, Masahiro Hiraoka, Kazue Tatsuno, Catherine D'Este PERCEPTIONS OF PSYCHOLOGICAL DISTRESS IN JAPANESE CANCER PATIENTS UNDERGOING RADIOTHERAPY TREATMENT PERCEPTIONS OF PSYCHOLOGICAL DISTRESS IN JAPANESE CANCER PATIENTS UNDERGOING RADIOTHERAPY TREATMENT PERCEPTIONS OF PSYCHOLOGICAL DISTRESS IN JAPANESE CANCER PATIENTS UNDERGOING RADIOTHERAPY TREATMENT ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 270-270 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 270-270 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 270-270 2012/11 English Summary of the papers read (international conference) Disclose to all
Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Maskazu Toi, Masahiro Hiraoka, Katsue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Maskazu Toi, Masahiro Hiraoka, Katsue Tatsuno, Catherine D'Este Lisa Mackenzie, Eiji Suzuki, Masakazu Ogura, Mariko Carey, Rob Sanson-Fisher, Hiromi Asada, Maskazu Toi, Masahiro Hiraoka, Katsue Tatsuno, Catherine D'Este JAPANESE CANCER PATIENTS' PREFERENCES FOR LIFE EXPECTANCY DISCUSSIONS JAPANESE CANCER PATIENTS' PREFERENCES FOR LIFE EXPECTANCY DISCUSSIONS JAPANESE CANCER PATIENTS' PREFERENCES FOR LIFE EXPECTANCY DISCUSSIONS ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 288-289 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 288-289 ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 288-289 2012/11 English Summary of the papers read (international conference) Disclose to all
光藤 悠子, 竹内 恵, 鈴木 栄治, 上野 貴之, 鍛 利幸, 杉江 知治, 金尾 昌太郎, 三上 芳喜, 石黒 洋, 戸井 雅和 光藤 悠子, 竹内 恵, 鈴木 栄治, 上野 貴之, 鍛 利幸, 杉江 知治, 金尾 昌太郎, 三上 芳喜, 石黒 洋, 戸井 雅和 傍腫瘍性神経症候群を契機に診断のついた潜在性乳癌の1例 傍腫瘍性神経症候群を契機に診断のついた潜在性乳癌の1例 日本乳癌学会総会プログラム抄録集20回, 499 日本乳癌学会総会プログラム抄録集20回, 499 , 499 2012/06 Disclose to all
金尾 昌太郎, 大西 奈都子, 片岡 正子, 杉江 知治, 上野 貴之, 竹内 恵, 鈴木 栄治, 辻 和香子, 戸井 雅和, 三上 芳喜, 富樫 かおり 金尾昌太郎, 大西奈都子, 片岡正子, 杉江知治, 上野貴之, 竹内恵, 鈴木栄治, 辻和香子, 戸井雅和, 三上芳喜, 富樫かおり 金尾 昌太郎, 大西 奈都子, 片岡 正子, 杉江 知治, 上野 貴之, 竹内 恵, 鈴木 栄治, 辻 和香子, 戸井 雅和, 三上 芳喜, 富樫 かおり 乳房MRIでspiculaを伴う病変に対するカテゴリー分類 乳房MRIでspiculaを伴う病変に対するカテゴリー分類 乳房MRIでspiculaを伴う病変に対するカテゴリー分類 日本乳癌学会総会プログラム抄録集, 20th, 339-339 日本乳癌学会学術総会プログラム・抄録集, 20th, 339-339 日本乳癌学会総会プログラム抄録集, 20th, 339-339 2012/05/30 Japanese Disclose to all
杉江 知治, 岡本 見, 宇野 伊津美, 南村 真紀, 光藤 悠子, 辻 和香子, 鈴木 栄治, 竹内 恵, 上野 貴之, 石黒 洋, 鍛 利幸, 戸井 雅和 杉江 知治, 岡本 見, 宇野 伊津美, 南村 真紀, 光藤 悠子, 辻 和香子, 鈴木 栄治, 竹内 恵, 上野 貴之, 石黒 洋, 鍛 利幸, 戸井 雅和 乳癌の生物学的特性にもとづく術前治療と縮小手術の試み 乳癌の生物学的特性にもとづく術前治療と縮小手術の試み 第 112 回 日 本外科学会 定期学術集会抄録集, 814 第 112 回 日 本外科学会 定期学術集会抄録集, 814 , 814 2012/04 Disclose to all
岡村 見, 鈴木栄治, 宇野伊津美, 南村真紀, 森龍太郎, 辻和香子, 竹内 恵, 上野貴之, 石黒 洋, 鍛 利幸, 杉江知治, 戸井雅和 岡村 見, 鈴木栄治, 宇野伊津美, 南村真紀, 森龍太郎, 辻和香子, 竹内 恵, 上野貴之, 石黒 洋, 鍛 利幸, 杉江知治, 戸井雅和 Turner 症候群に併発した乳癌の一例 Turner 症候群に併発した乳癌の一例 第63回 京滋乳癌研究会 プログラム・抄録集, 6 第63回 京滋乳癌研究会 プログラム・抄録集, 6 , 6 2012/03 Disclose to all
E Suzuki, Kapoor, V, AS Jassar, A Haas, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, AS Jassar, A Haas, LR Kaiser, SM Albelda E Suzuki, Kapoor, V, AS Jassar, A Haas, LR Kaiser, SM Albelda Augmentation of immuno-gene therapy for lung cancer using chemotherapy Augmentation of immuno-gene therapy for lung cancer using chemotherapy Augmentation of immuno-gene therapy for lung cancer using chemotherapy MOLECULAR THERAPY, 9, S215-S216 MOLECULAR THERAPY, 9, S215-S216 MOLECULAR THERAPY, 9, S215-S216 2004/05 English Summary of the papers read (international conference) Disclose to all
K Matsuoka, K Tsukuda, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, N Shimizu K Matsuoka, K Tsukuda, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, N Shimizu K Matsuoka, K Tsukuda, T Ota, A Okita, K Watanabe, E Suzuki, M Murakami, N Shimizu The relation of thymidylate synthase activity and the antitumor effect of 5-fluorouracil The relation of thymidylate synthase activity and the antitumor effect of 5-fluorouracil The relation of thymidylate synthase activity and the antitumor effect of 5-fluorouracil INTERNATIONAL JOURNAL OF CANCER, 435-435 INTERNATIONAL JOURNAL OF CANCER, 435-435 INTERNATIONAL JOURNAL OF CANCER, 435-435 2002 English Summary of the papers read (international conference) Disclose to all
K Watanabe, T Ota, D Toda, M Okita, K Matsuoka, E Suzuki, M Naitou, M Murakami, N Shimizu K Watanabe, T Ota, D Toda, M Okita, K Matsuoka, E Suzuki, M Naitou, M Murakami, N Shimizu K Watanabe, T Ota, D Toda, M Okita, K Matsuoka, E Suzuki, M Naitou, M Murakami, N Shimizu Evaluation of chemosensitivity test using collagen gel droplet culture method in case of advanced gastrointestinal cancer Evaluation of chemosensitivity test using collagen gel droplet culture method in case of advanced gastrointestinal cancer Evaluation of chemosensitivity test using collagen gel droplet culture method in case of advanced gastrointestinal cancer INTERNATIONAL JOURNAL OF CANCER, 434-434 INTERNATIONAL JOURNAL OF CANCER, 434-434 INTERNATIONAL JOURNAL OF CANCER, 434-434 2002 English Summary of the papers read (international conference) Disclose to all

  • <<
  • >>
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells Exploration of metastatic brain tumor microenvironment specific molecular properties of immune cells and breast cancer cells 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier 2019/01 English Oral presentation(general) Disclose to all
Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer Patritumab (anti-HER3 antibody) augments anti-tumor immune response of adoptive transfer of autologous activated T cells for patient-derived xenograft models of breast cancer ESMO ESMO ESMO 2018 English Poster presentation Disclose to all
Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Potential role of lipid metabolic network related to anti-tumor immune response in breast cancer microenvironment Cell Symposia Cell Symposia Cell Symposia 2018 Disclose to all
HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義[Invited] HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義 [Invited] HER2陽性乳癌治療戦略における治療効果/耐性メカニズムの免疫学的意義 [Invited] 第26回日本乳癌学会学術総会ワークショップ 第26回日本乳癌学会学術総会ワークショップ 2018 Disclose to all
Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test Gene expression profile of peripheral blood mononuclear cells in breast cancer patients may contribute to the identification and the immunological classification of breast cancer patients by blood test AACR AACR AACR 2017 Disclose to all
Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis Proteomics analysis of breast cancer cell-specific proteins that are transferred to immune cells via trogocytosis AACR AACR AACR 2016 Disclose to all
EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients EGFR is transferred from triple negative breast cancer cells to immune cells via trogocytosis and expression of EGFR on immune cells is associated with high tumor grade of triple negative breast cancer patients AACR AACR AACR 2015 Disclose to all
A role of trogocytosis of immune cells in breast tumor microenvironment[Invited] A role of trogocytosis of immune cells in breast tumor microenvironment [Invited] A role of trogocytosis of immune cells in breast tumor microenvironment [Invited] 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 20th World Congress on Advances in Oncology and 18th International Symposium on Molecular Medicine 2015 Disclose to all
Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity Loss of HER2 via trogocytosis by CD14+ cells in HER2 overexpressing breast cancer cells are associated with diminishing of trastuzumab mediated antibody dependent cellular cytotoxicity AACR AACR AACR 2014 Disclose to all
Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells Upregulation of neuropilin-1 in human monocyte is induced by RANKL and may be associated with trastuzumab mediated antibody dependent cellular cytotoxicity in breast cancer cells AACR AACR AACR 2013 Disclose to all
Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients Acceptability of touch screen computer psychosocial survey to Japanese radiation therapy patients COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology 2012 Disclose to all
bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells bility of serum vascular endothelial growth factor in advanced or metastatic colorectal cancer patients to inhibit lymphokine activated killer cells AACR AACR AACR 2011 Disclose to all
Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells Serum vascular endothelial growth factor in advanced breast cancer patients might be a key role of inhibitory effect on lymphokine activated killer cells AACR AACR AACR 2010 Disclose to all
Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line Serum from breast cancer patients shows either augmentation or inhibition of lymphokine activated killer cells against human breast cancer cell line AACR AACR AACR 2008 Disclose to all

  • <<
  • >>
Title language:
Books etc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Publisher Publisher(Japanese) Publisher(English) Publication date Language Type Disclose
Eiji Suzuki, Steven M. Albelda Eiji Suzuki, Steven M. Albelda Eiji Suzuki, Steven M. Albelda Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Soluble Type II Transforming Growth Factor-b Receptor Inhibits Tumorigenesis by Augmenting Host Antitumor Immunity Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 2013-2015
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 (平成26年度分) 2014/04/01-2015/03/31
基盤研究(C) Representative 乳癌に対するトラスツズマブ効果予測因子としてのニューロピリン1陽性免疫細胞の意義 (平成27年度分) 2015/04/01-2016/03/31
基盤研究(C) Representative 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 (平成29年度分) 2017/04/01-2018/03/31
基盤研究(C) Representative 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 (平成30年度分) 2018/04/01-2019/03/31
基盤研究(C) Representative 乳癌微小環境におけるマクロファージの脳転移特異的な役割の解明 (2019年度分) 2019/04/01-2020/03/31
Teaching subject(s)
Name(Japanese) Name(English) Term Department Period
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2014/04-2015/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2015/04-2016/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2016/04-2017/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部(人間健康科学科) 2017/04-2018/03
生殖科学II Reproductive Science II 前期 医学研究科(人間健康科学系専攻) 2018/04-2019/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 医学部(人間健康科学科) 2019/04-2020/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 薬学部 2019/04-2020/03
生殖科学II Reproductive Science II 前期 医学研究科(人間健康科学系専攻) 2020/04-2021/03
がん看護学特論I Advanced Cancer Nursing Lecture I 前期 医学研究科(人間健康科学系専攻) 2020/04-2021/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 医学部(人間健康科学科) 2020/04-2021/03
臨床疾病論G Clinical Overview of Medicine G 前期後半 薬学部 2020/04-2021/03

  • <<
  • >>
Faculty management (title, position)
Title Period
リスクマネージャー会議 委員 2011/04/01-
病棟医長・看護師長会議 委員 2013/02/01-